Research Program/

Frontier Biotechnology in Emerging Diseases

“Emerging diseases” are an important public health problem that can lead to disasters threatening national security, and cause health and economic burdens. At present, the rate of emerging diseases is rapidly increasing. As a recent example, by the end of the year 2019, a pandemic outbreak of novel Coronavirus (SARS-nCoV-2) or COVID-19, began in Wuhan, China and rapidly spread worldwide. 

In 2013, Professor Kiat Ruxrungtham established the Integrated Frontier Biotechnology in responses to Emerging Diseases, gathering professors and researchers from various fields. This will enable Thailand to have an infrastructure that is sustainable and self-reliant in surveillance, prevention, treatment, and effective response to emerging diseases in the future.

Focusing on integrated frontier biotechnology in response to emerging diseases, Thailand should not be just a buyer, we should be a developer as well
Asst.Prof.Chutitorn Ketloy
Director of Emerging Infectious Diseases

Focus Areas

  • Using integrated frontier biotechnology for the diagnosis, treatment, and prevention of emerging diseases

Partnerships

Faculty of Science
Faculty of Engineering
Mahidol University
Bionet
Chula Vaccine
research Center (VRC)
Faculty of
Pharmaceutical Sciences
International Society for
the Psychoanalytic Study of Organizations
Kingen Biotech
National Primate Research Center
University of Copenhagen,
Denmark
university of geneva,
switzerland
University of Pennsylvania,
United States
Walter Reed Army Institute
of Research (WRAIR)
Chiang Mai University

Research Highlights

Publications

  • Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772. PMID: 32105090.

Contact

Asst.Prof.Chutitorn Ketloy
Emerging Infectious Diseases, Chula Vaccine Research Center (Chula VRC), Chulalongkorn University

E-mail: chutitorn.k@chula.ac.th